glp 1 therapy GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies The Benefits of GLP-1 Therapy:

Compounded GLP-1 and dual GIP/GLP-1 receptor agonists: A statement from the American Diabetes Association

For example, a dose as small as 1 to 5 mg could cause seizures

Partial loading dose is equal to (wt in kg)(0.7)(target phenytoin level current phenytoin level)

Note: These effects are observed and interpreted from clinical studies and should not be understood as direct personal guarantees for blood glucose or weight support

Exceeding recommended doses (typically above 1,000 mg/day) increases the likelihood of digestive side effects such as bloating, cramping, and loose stools

To minimize side effects, we start with a low dose and gradually increase it